ONC
BeOne Medicines Ltd.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$358.26
−1.22%Forward multiples
Based on analyst estimates
- P/E forward
- 45.66x
- P/E 2026E
- 48.21x
- P/E 2027E
- 35.40x
- P/E 2028E
- 26.12x
- P/S forward
- 5.64x
Trailing multiples
Trailing twelve months
- P/E TTM
- 4.71x
- PEG TTM
- —
- Price / book
- 7.87x
- Price / sales
- 6.65x
- Price / cash flow
- 24.16x
Enterprise value
- Enterprise value
- $36.8B
- EV / sales
- 6.00x
- EV / EBITDA
- 31.72x
- EV / EBIT
- 39.84x
- Market cap
- $40.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026